Spots Global Cancer Trial Database for Study of Dentoxol® Mouthrinse for Oral Mucositis

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Study of Dentoxol® Mouthrinse for Oral Mucositis

Official Title: Phase II Study of Dentoxol® Mouthrinse for Oral Mucositis Secondary to Radiation Therapy for Head and Neck Cancer

Study ID: NCT02885376

Conditions

Oral Mucositis

Interventions

Dentoxol

Placebo

Study Description

Brief Summary: The primary objective of this study is to determine the efficacy of Dentoxol® mouthrinse in reducing the severity of oral mucositis secondary to radiation therapy for head and neck cancer.

Detailed Description:

Keywords

Mucositis

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Clinica IRAM, Santiago, , Chile

Fundación Arturo López Pérez, Santiago, , Chile

Instituto Nacional del Cáncer, Santiago, , Chile

Contact Details

Name: Sebastián Sole

Affiliation: Clinica IRAM

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: